AGMB

MKT CAP:$543M

AgomAb Therapeutics N.V. American Depositary Shares

Market Cap

$543M

Healthcare·Biotechnology·🇧🇪 Belgium·NASDAQ

Healthcare·Biotechnology·🇧🇪·NASDAQ

Stock Price

$10.70-$3.95 (-26.96%)

Apr 23, 2026

Company Details

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. The company's pro...

CEO

Tim Knotnerus

IPO Date

May 29, 2024

Website

agomab.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$14M

EPS (Diluted)

-$0.38

Free Cash Flow

-$15M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

FY 2024

Dec 31, 2024

$0EPS -$1.47

Q4 2024

Dec 31, 2024

$0EPS -$0.38

FY 2023

Dec 31, 2023

$0EPS -$0.36

FY 2022

Dec 31, 2022

$0EPS -$0.26

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 24	$0	$0	-$14M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 24	-$15M	-$15M

Capital Expenditures

Quarter	CapEx
Q4 24	$424.4K

CapEx

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 24	$583.4K	—

OpEx Breakdown

Quarter	R&D	G&A
Q4 24	$13M	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 24	$200M	$0	$200M
Q3 25	$152M	$0	$152M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 24	36M	—	—

Shares Outstanding